The market seems to want to move higher, albeit slowly and with rude interruptions from the headlines. The S&P 500 is within less than 1% off the all-time high set in July, although the index has been somewhat range-bound since June.
Read More
Two portfolio stocks delivered strong earnings beats are their recommendations are raised to Strong Buy. A third stock delivered a strong earnings beat.
Read More
One portfolio stock is up on news of a successful drug trial and another reported a strong earnings beat.
Read More
Short-term, the market remains under pressure, buffeted by the selling of investors scared by the prospects of an extended tariff war, but long-term, the trend remains up, so we still see the current weakness as a normal correction.
Read More
When market pundits toss about terms like “growth stocks” and “value stocks,” it seems as if they’re saying “companies that are growing” vs. “companies that are not growing,” so we sugar-coat these companies and pretend that they have ‘value.” That’s not really what vs...
Read More
Impeachment proceedings and the stock market don't seem like a good mix. But past history of them paints a surprising picture.
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
From Cabot Top Ten Trader
The market had another decent week, with the major indexes finishing above key moving averages, though all are still stuck in multi-month ranges. But the calm action hid another round of vicious rotation beneath the surface, with most growth-oriented at...
Read More
The next stock market run-up is long overdue. According to the charts, it's almost historically overdue. Here's how to play it.
Read More
There is a lot of uncertainty out there, which isn’t an entirely new scenario. We’ll continue to try and play it a little safe right now by keeping all stocks previously rated hold at the same rating.
Read More
Baker Hughes changes their corporate name and stock symbol. And, two stocks report third-quarter earnings beats.
Read More
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Two stocks report earnings and two more are rising again.
Read More
It’s been a tough few months for cannabis investors, but no downtrend lasts forever, and yesterday’s blast-off by Aphria (APHA), which sparked buying across the sector, is a sign that the worst has almost certainly passed.
Read More
Market Views
Quiet for Now
Stocks finished a relatively quiet session lower today, after trading on both sides of breakeven amid waning optimism over Friday's partial trade deal between Beijing and Washington. Reports emerged that China wishes to continue trade talks before finalizing the "phase deal,...
Read More
The market is once again flirting with all time highs. The good week was driven largely by the announcement of a partial trade deal with China. But the main event will be earnings going forward.
Read More
Stocks in this Issue
Five Portfolio Management Tips for Early-Stage Stocks
The nature of this newsletter is that 90% of our focus is centered on finding early-stage opportunities and vetting them. But to have investing success – in any type of stocks – over the haul...
Read More
Short-term, the market remains under pressure, buffeted by the selling of investors scared by the prospects of an extended tariff war, but long-term, the trend remains up, so we still see the current weakness as a normal correction.
Read More
Donald Trump's early stock market results have been stronger than expected through his first three post-election years. How do they stack up to Obama's?
Read More
